Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Nasal Sprays × Clear all

Status

Sponsor Class

Study Type

Observational 2

Sponsor

Conditions

Breakthrough Cancer Pain 2

Interventions

Cyclophosphamide 2746 Cisplatin 2723 Carboplatin 2524 Radiotherapy 2433 Paclitaxel 2313 Gemcitabine 2172 pembrolizumab 2029 Docetaxel 1916 Bevacizumab 1869 Fluorouracil 1583 Capecitabine 1578 Oxaliplatin 1478 Dexamethasone 1362 Nivolumab 1335 Doxorubicin 1285 Rituximab 1278 Magnetic Resonance Spectroscopy 1176 Etoposide 1147 Irinotecan 1067 Leucovorin 1048 Drug Therapy 1024 Cytarabine 987 fludarabine 913 Pemetrexed 906 Specimen Handling 845 Vincristine 813 Lenalidomide 810 Cetuximab 805 Trastuzumab 804 Prednisone 803

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01693328 2014-01-15

Qualipec

Archimedes Development Ltd

Breakthrough Cancer Pain

NCT01698645 2013-07-11

Qualipec

Archimedes Development Ltd

Breakthrough Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡